Similar Search Results

Calculating an intervention's (cost-)effectiveness for the real-world target population: The potential of combining strengths of both RCTs and observational data

Neyt, Mattias; Cleemput, Irina; Thiry, Nancy; De Laet, Chris - In: Health Policy 106 (2012) 2, pp. 207-210

Economic evaluations most often use results from randomised controlled trials (RCTs) to model effectiveness …

Persistent link: https://www.econbiz.de/10010573145

The Austrian Tobacco Act in practice – Analysing the effectiveness of partial smoking bans in Austrian restaurants and bars

Reichmann, Gerhard; Sommersguter-Reichmann, Margit - In: Health Policy 104 (2012) 3, pp. 304-311

The purpose of this study is to examine the effectiveness of partial smoking bans in restaurants and bars, such as …

Persistent link: https://www.econbiz.de/10010576994

Comprehensive care programs for patients with multiple chronic conditions: A systematic literature review

Bruin, Simone R. de; Versnel, Nathalie; Lemmens, Lidwien C. - In: Health Policy 107 (2012) 2, pp. 108-145

To provide insight into the characteristics of comprehensive care programs for patients with multiple chronic conditions and their impact on patients, informal caregivers, and professional caregivers.

Persistent link: https://www.econbiz.de/10010580665

Efficiency, effectiveness, equity (E3). Evaluating hospital performance in three dimensions

Davis, Peter; Milne, Barry; Parker, Karl; Hider, Phil; … - In: Health Policy 112 (2013) 1, pp. 19-27

There are well-established frameworks for comparing the performance of health systems cross-nationally on multiple dimensions. A sub-set of such comprehensive schema is taken up by criteria specifically applied to health service delivery, including hospital performance.

Persistent link: https://www.econbiz.de/10010709313

A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe

Campillo-Artero, Carlos - In: Health Policy 113 (2013) 1, pp. 38-44

The unacceptably high incidence of clinical adverse events caused by medical devices (MDs), their high recall rates, and the frequent phase out of some of the devices that pose a greater risk to health have triggered alarm concerning the long-standing weaknesses of their regulatory processes. It...

Persistent link: https://www.econbiz.de/10010719296

Effects of pay for performance in health care: A systematic review of systematic reviews

Eijkenaar, Frank; Emmert, Martin; Scheppach, Manfred; … - In: Health Policy 110 (2013) 2, pp. 115-130

A vast amount of literature on effects of pay-for-performance (P4P) in health care has been published. However, the evidence has become fragmented and it has become challenging to grasp the information included in it.

Persistent link: https://www.econbiz.de/10011048318

Policies to improve the health and well-being of Roma people: The European experience

Fésüs, Gabriella; Östlin, Piroska; McKee, Martin; … - In: Health Policy 105 (2012) 1, pp. 25-32

situation of Roma communities in the Region and identifies factors that may limit the effectiveness of these policy initiatives …

Persistent link: https://www.econbiz.de/10011048325

National Cancer Screening Programs and Evidence-Based Healthcare Policy in South Korea

Jung, Minsoo - In: Health Policy 119 (2015) 1, pp. 26-32

South Korea has managed its National Cancer Screening Program (NCSP) since 1999 with free cancer screenings for the five major types of cancer (stomach, liver, colorectal, breast, and cervical cancer). Despite the tremendous amount of government funding, the necessity of this policy and...

Persistent link: https://www.econbiz.de/10011190159

Experience with outcomes research into the real-world effectiveness of novel therapies in Dutch daily practice from the context of conditional reimbursement

Gaultney, Jennifer G.; Franken, Margreet G.; Uyl-de … - In: Health Policy 119 (2015) 2, pp. 186-194

-world patients treated as of May 2009 (RW-1; n=72) and June 2012 (RW-2; n=129). Prognosis, treatment, and effectiveness were compared … was limited however in generating robust evidence on real-world safety and effectiveness. The quality of real …-world evidence on effectiveness was low due to missing data in patient charts, existing treatment variation and the dynamics in care …

Persistent link: https://www.econbiz.de/10011190162